This document contains daily reports from a medical representative named George Mobarak over several days. On Saturdays and Sundays, the representative has official holidays with no morning activities reported. On Mondays and Tuesdays, the representative has regular holidays with no morning activities reported. The reports otherwise leave sections for hospital/institution name, doctor name, specialty, products detailed, and pharmacists blank.
This document contains daily reports from a medical representative named George Mobarak over several days. On Saturdays and Sundays, the representative has official holidays with no morning activities reported. On Mondays and Tuesdays, the representative has regular holidays with no morning activities reported. The reports otherwise leave sections for hospital/institution name, doctor name, specialty, products detailed, and pharmacists blank.
This document contains daily reports from a medical representative named George Mobarak over several days. On Saturdays and Sundays, the representative has official holidays with no morning activities reported. On Mondays and Tuesdays, the representative has regular holidays with no morning activities reported. The reports otherwise leave sections for hospital/institution name, doctor name, specialty, products detailed, and pharmacists blank.
This document contains daily reports from a medical representative named George Mobarak over several days. On Saturdays and Sundays, the representative has official holidays with no morning activities reported. On Mondays and Tuesdays, the representative has regular holidays with no morning activities reported. The reports otherwise leave sections for hospital/institution name, doctor name, specialty, products detailed, and pharmacists blank.
This document is Amoun Pharmaceutical Co. confidential and proprietary information. Individuals printing a copy of an Amoun procedural document are responsible for ensuring that revisions to the document have not been issued since it was printed. Form Code Amoun Pharmaceutical Co. S.A.E. EGP-S&M-GEN-SOP-004- Med Rep’s Daily Report F02
Med Rep’s Signature: .............................................................................
SSS-FRM-NNN Version 1 Page 1 of 2
This document is Amoun Pharmaceutical Co. confidential and proprietary information. Individuals printing a copy of an Amoun procedural document are responsible for ensuring that revisions to the document have not been issued since it was printed.
Notice: Human Drugs: Drug Products Withdrawn From Sale For Reasons Other Than Safety or Effectiveness— Celestone Soluspan Injection and Celestone Injection